Short-term Perioperative Thromboprophylaxis After Major Abdominal Surgery
NCT04709510 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 89
Last updated 2021-01-14
Summary
Major abdominal surgery for cancer is major risk factor for thromboembolism. Patients who undergo major abdominal surgery are prone to develop venous thromboembolism, both in the early postoperative period and after hospital discharger. There are strong recommendations in the international guidelines in favor to pharmacological thromboprophylaxis. Thus there is no consensus dor the duration of the prophylaxis. There are authors that suggest extended prophylaxis up to 4 week after surgery. On the other hand, there are prospective randomized trials that inpatient (short-term up to 7-10 days) prophylaxis is adequate.
Conditions
- Deep Vein Thrombosis
Interventions
- DIAGNOSTIC_TEST
-
Duplex Ultrasound
Duplex Ultrasound was performed for every participants for the diagnosis of symptomatic or asymptomatic deep vein thrombosis
Sponsors & Collaborators
-
Istanbul Medeniyet University
lead OTHER
Principal Investigators
-
Orhan Alimoglu, Prof · Istanbul Medeniyet University
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-01-01
- Primary Completion
- 2019-12-31
- Completion
- 2020-08-31
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
ONE WEEK VERSUS FOUR WEEK HEPARIN PROPHYLAXIS AFTER LAPAROSCOPIC SURGERY FOR COLORECTAL CANCER.
NCT01589146 ·Status: UNKNOWN ·Phase: PHASE3
-
Thrombin Generation and Platelet Activation in CRS/HIPEC
NCT03034850 ·Status: COMPLETED
-
Incidence of Venous Thromboembolism Following Surgery in Patients With Colorectal Cancer
NCT01567917 ·Status: UNKNOWN
-
Perioperative Coagulopathy in Patients Undergoing Cytoreductive Surgery and HIPEC Intraperitoneal Chemotherapy (HIPEC)
NCT03956836 ·Status: COMPLETED
-
Venous Thromboembolism in Primary Pancreatic Tumour Resection
NCT05964621 ·Status: RECRUITING
-
Changes in Coagulation in Colorectal Cancer Patients Undergoing Surgical Treatment
NCT04744688 ·Status: COMPLETED
-
Effect of Peritoneal Lavage on Surgery-induced Positive Peritoneal Cytology in Gastric Cancer Patients
NCT02287168 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Gastric Cancer Surgery in Elderly Patients
NCT03777540 ·Status: COMPLETED
-
Preventive Effect of Enoxaparin, Pentoxifylline and Ursodeoxycholic Acid to Radiation Induced Liver Toxicity
NCT01149304 ·Status: COMPLETED ·Phase: PHASE2
-
Alternative Surgical Policy for Central Liver Tumors
NCT00600522 ·Status: COMPLETED
-
A Nomogram to Predict Major Postoperative Complications After Cytoreductive Surgery and HIPEC Based on Pre and Peroperative Criteria: Which Patient Require Intensive Monitoring?
NCT05547568 ·Status: COMPLETED
-
A Phase Ib/II Study of Efficacy and Feasibility of Cytoreductive Surgery, Extensive Peritoneal Lavage, Hyperthermicintraperitoneal Chemotherapy and Post-operative Intraperitoneal Chemotherapy Combination in Gastric Cancer With Peritoneal Metastasis
NCT02995850 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Prognostic Value Related to the Presence of Thrombosis or Portal Vein Invasion in Patients With Hepatocellular Carcinoma Submitted to Surgery
NCT01690715 ·Status: TERMINATED
-
Effectiveness of Managing Suspected Metastasis and Progress Using Plasma D-dimer Testing in Gastric Cancer Patients
NCT04953585 ·Status: COMPLETED
-
A Multicenter, Open-Label, Non-Inferiority Randomized Controlled Trial of Postoperative VTE Prevention in Chinese Patients After Colorectal Cancer Surgery
NCT06583330 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Rivaroxaban or Placebo for Extended Antithrombotic Prophylaxis After Laparoscopic Surgery for Colorectal Cancer.
NCT03055026 ·Status: COMPLETED ·Phase: PHASE3
-
Current Role of Pentafecta Outcomes in Open and Laparoscopic Partial Nephrectomy for Localized Renal Tumors
NCT06969131 ·Status: COMPLETED ·Phase: NA
-
Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Gastric Cancer
NCT04180761 ·Status: WITHDRAWN ·Phase: PHASE2
-
Postoperative Morbidity and Mortality After Gastric Cancer Surgery
NCT06277908 ·Status: NOT_YET_RECRUITING
-
The Incidence of Pulmonary Embolism During Nephrectomy
NCT04402749 ·Status: COMPLETED
-
The Safety and Feasibility of Laparoscopic-assisted Gastrectomy for Advanced Gastric Cancer After Neoadjuvant Chemotherapy
NCT02902575 ·Status: COMPLETED ·Phase: NA
-
A Study of Initiation Timing of VTE Prevention After Colorectal Cancer Surgery
NCT06259149 ·Status: RECRUITING
-
Resection of the Inferior Vena Cava Due to Tumor Involvement
NCT04154761 ·Status: COMPLETED
-
Postoperative Morbidity and Mortality After Gastrectomy for Gastric Cancer: Prospective Cohort Study
NCT01919242 ·Status: UNKNOWN
-
Incidence Rate of Perioperiative VTE in Colorectal Cancer Patients : a Multicenter Prospective Observational Cohort Study
NCT04588805 ·Status: UNKNOWN